why choose us

First received: September 12, 2022

Clinical Trial: ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer

Study Status: Completed

Recruit Status: RECRUITING

Condition: Endometrial Cancer

Study Type: INTERVENTIONAL


Official Title: Phase 1 Clinical Trial of ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer

Brief Summary: Endometrial cancer (EC) is the fourth most common cancer in United States women, and alarmingly, the frequency and mortality from EC continues to rise, in part due to the obesity epidemic.Obese women with EC have a 6.3-fold increased risk of death from this disease, as compared to their non-obese counterparts.Patients with advanced/recurrent EC are unlikely to be cured by surgery, conventional chemotherapy (paclitaxel + carboplatin is the standard first-line treatment), radiation, or a combination of…

Read more